Investigating the Architecture of HIV Envelope Glycoprotein

研究 HIV 包膜糖蛋白的结构

基本信息

  • 批准号:
    8262992
  • 负责人:
  • 金额:
    $ 4.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-02-01 至 2014-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The human immunodeficiency virus (HIV) employs an array of properties that enable it to evade antibody neutralization. Rational vaccine design has been limited due to the insufficient structural understanding of the HIV envelope glycoprotein (Env), the primary target for neutralizing antibodies. Advances in structural determination have been hindered due to the presence of flexible hypervariable loops and the high carbohydrate content of this protein and the arrangement of the full Env complex remains controversial. The nature of the glycan shield, thought to mask conserved sites, is also of key interest as it mediates immune escape. Furthermore the binding of host cell CD4 receptor is known to induce massive conformational changes in Env, but a detailed examination of these changes has yet to be addressed. This proposal aims to combine two complementary approaches, small-angle X-ray scattering (SAXS) with ab initio shape reconstruction and hydrogen-deuterium exchange (HXMS) with mass spectrometry analysis to address several questions regarding the architecture of trimeric Env. The extensive catalog of constructs available from the Hu lab enables comparative studies of Env ranging from monomeric subunits to trimeric complexes, in the context of the same isolate. Identification of the trimeric interface, conformational changes induced upon receptor binding, and epitope occlusion by variable loops and glycans can be addressed with these techniques. The interaction of several well-characterized monoclonal antibodies directed against the CD4 binding site will also be compared to address the question of how conformational changes induced by antibody binding differ from those resulting from CD4 binding, and whether there are potentially correlates with neutralizing potency. Understanding these properties of Env will assist current efforts to identify targets for development of broadly neutralizing antibodies, necessary for an effective vaccine. PUBLIC HEALTH RELEVANCE: The poor understanding of the primary surface protein of the Human Immunodeficiency Virus (HIV) has been a major hindrance to vaccine development. A thorough understanding of the organization of this protein is critical for designing next generation immunogens to induce an effective immune response. Using two emerging techniques we will address uncertainties regarding the architecture of this surface protein, identify how critical antigenic regions are protected, and identify ways to improve vaccine design.
描述(由申请人提供):人类免疫缺陷病毒(HIV)利用一系列特性使其能够逃避抗体中和。由于对中和抗体的主要靶标 HIV 包膜糖蛋白 (Env) 的结构了解不足,合理的疫苗设计受到限制。由于柔性高变环的存在和该蛋白质的高碳水化合物含量,结构测定的进展受到阻碍,并且完整的 Env 复合物的排列仍然存在争议。聚糖屏蔽的性质被认为可以掩盖保守位点,但由于它介导免疫逃逸,因此也具有重要意义。此外,已知宿主细胞 CD4 受体的结合会诱导 Env 发生巨大的构象变化,但对这些变化的详细检查尚未解决。 该提案旨在结合两种互补的方法,即小角度 X 射线散射 (SAXS) 与从头形状重建和氢氘交换 (HXMS) 与质谱分析,以解决有关三聚 Env 结构的几个问题。 Hu 实验室提供的广泛构建体目录使得能够在同一分离物的背景下对从单体亚基到三聚体复合物的 Env 进行比较研究。通过这些技术可以解决三聚体界面的识别、受体结合引起的构象变化以及可变环和聚糖引起的表位封闭。还将比较几种针对 CD4 结合位点的已充分表征的单克隆抗体的相互作用,以解决抗体结合引起的构象变化与 CD4 结合引起的构象变化有何不同,以及是否与中和效力潜在相关的问题。了解 Env 的这些特性将有助于当前确定开发有效疫苗所必需的广泛中和抗体的目标。 公共卫生相关性:对人类免疫缺陷病毒 (HIV) 主要表面蛋白的了解不足一直是疫苗开发的主要障碍。彻底了解这种蛋白质的组织对于设计下一代免疫原以诱导有效的免疫反应至关重要。使用两种新兴技术,我们将解决有关该表面蛋白结构的不确定性,确定如何保护关键抗原区域,并确定改进疫苗设计的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Miklos Guttman其他文献

Miklos Guttman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Miklos Guttman', 18)}}的其他基金

ThermoFisher Scientific Orbitrap Eclipse with ETD and UVPD
带 ETD 和 UVPD 的 ThermoFisher Scientific Orbitrap Eclipse
  • 批准号:
    10427682
  • 财政年份:
    2022
  • 资助金额:
    $ 4.92万
  • 项目类别:
Mechanisms of IgM mediated activation of the complement system
IgM 介导的补体系统激活机制
  • 批准号:
    10416077
  • 财政年份:
    2021
  • 资助金额:
    $ 4.92万
  • 项目类别:
Mechanisms of IgM mediated activation of the complement system
IgM 介导的补体系统激活机制
  • 批准号:
    10296558
  • 财政年份:
    2021
  • 资助金额:
    $ 4.92万
  • 项目类别:
Mechanisms of IgM mediated activation of the complement system
IgM 介导的补体系统激活机制
  • 批准号:
    10640282
  • 财政年份:
    2021
  • 资助金额:
    $ 4.92万
  • 项目类别:
Multistage LC-MSn for automated glycan isomer assignment of glycopeptides
用于糖肽自动聚糖异构体分配的多级 LC-MSn
  • 批准号:
    10255170
  • 财政年份:
    2021
  • 资助金额:
    $ 4.92万
  • 项目类别:
Hybrid structural mass spectrometry for rapid site-specific glycan structural elucidation
用于快速位点特异性聚糖结构解析的混合结构质谱法
  • 批准号:
    10186777
  • 财政年份:
    2018
  • 资助金额:
    $ 4.92万
  • 项目类别:
Investigating the Architecture of HIV Envelope Glycoprotein
研究 HIV 包膜糖蛋白的结构
  • 批准号:
    8432517
  • 财政年份:
    2012
  • 资助金额:
    $ 4.92万
  • 项目类别:

相似海外基金

Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
  • 批准号:
    10574738
  • 财政年份:
    2023
  • 资助金额:
    $ 4.92万
  • 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
  • 批准号:
    10392870
  • 财政年份:
    2021
  • 资助金额:
    $ 4.92万
  • 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
  • 批准号:
    10092930
  • 财政年份:
    2020
  • 资助金额:
    $ 4.92万
  • 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
  • 批准号:
    9896170
  • 财政年份:
    2020
  • 资助金额:
    $ 4.92万
  • 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
  • 批准号:
    433456
  • 财政年份:
    2020
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
  • 批准号:
    19K15765
  • 财政年份:
    2019
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
  • 批准号:
    9932769
  • 财政年份:
    2018
  • 资助金额:
    $ 4.92万
  • 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
  • 批准号:
    BB/P504713/1
  • 财政年份:
    2017
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
  • 批准号:
    1932904
  • 财政年份:
    2017
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
  • 批准号:
    1632399
  • 财政年份:
    2016
  • 资助金额:
    $ 4.92万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了